Aristo Bio-Tech IPO vs Ducol Organics IPO

Comparison between Aristo Bio-Tech IPO and Ducol Organics IPO.

IPO Details

Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Ducol Organics IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the Ducol Organics IPO is up to ₹28.38 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of Ducol Organics IPO is ₹78.00 per share.

 Aristo Bio-Tech IPODucol Organics IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹72.00 per share₹78.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares1600 shares
Fresh Issue Size17,21,600 shares36,38,400 shares
Fresh Issue Size (Amount)up to ₹12.40 Crup to ₹28.38 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total17,21,600 shares36,38,400 shares
Issue Size Total (Amount)up to ₹12.40 Crup to ₹28.38 Cr

IPO Timetable

Aristo Bio-Tech IPO opens on Jan 16, 2023, while Ducol Organics IPO opens on Jan 09, 2023. The closing date of Aristo Bio-Tech IPO and Ducol Organics IPO is Jan 19, 2023, and Jan 11, 2023, respectively.

 Aristo Bio-Tech IPODucol Organics IPO
Issue OpenJan 16, 2023Jan 09, 2023
Issue CloseJan 19, 2023Jan 11, 2023
Basis Of Allotment (Tentative)Jan 24, 2023Jan 16, 2023
Initiation of Refunds (Tentative)Jan 25, 2023Jan 17, 2023
Credit of Share (Tentative)Jan 27, 2023Jan 18, 2023
Listing date (Tentative)Jan 30, 2023Jan 19, 2023

Financials & KPIs

Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to Ducol Organics IPO P/E ratio of 13.59.

 Aristo Bio-Tech IPODucol Organics IPO
Financials

Company Financials (Restated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets108.6977.0081.4287.85
Total Income129.07166.03167.23201.24
Profit After Tax2.591.461.081.01
NET Worth17.4314.8413.3812.31
Reserves and Surplus12.449.858.397.31
Total Borrowing29.3625.4822.2519.71
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets60.5563.4857.1061.40
Total Income48.7588.9478.8673.72
Profit After Tax4.174.912.810.07
NET Worth24.8520.9016.1114.06
Reserves and Surplus14.9018.5313.9011.06
Total Borrowing13.5019.9216.5722.97
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%79.46%
Promoter Shareholding (Post-Issue)73.37%57.38%
P/E Ratio9.4613.59
Market Cap₹49.02 Cr.₹113.41 Cr.
ROE29.26
ROCE35.64
Debt/Equity5.10
EPS₹2.93₹4.68
RoNW1023.5

Shares Offered

In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in Ducol Organics IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and in Ducol Organics IPO.

 Aristo Bio-Tech IPODucol Organics IPO
Market Maker Reservation91,200 shares4,01,600 shares
NII8,60,800 shares18,19,200 shares
RII8,60,800 shares18,19,200 shares
Total17,21,600 shares36,38,400 shares

Bids Received (Subscription)

Aristo Bio-Tech IPO subscribed 217.72x in total, whereas Ducol Organics IPO subscribed 44.63x.

 Aristo Bio-Tech IPODucol Organics IPO
NII (times)285.84x58.15x
RII (times)149.59x31.11x
Total (times)217.72x44.63x

Compare with others

Compare: